Delivery Order SPE2DR25D2022-SPE2DR26F2ZQE

The Defense Logistics Agency awarded a delivery order valued at $1,729.69 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of January 15, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as the corporate headquarters for the awardee. This delivery order represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s, larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at up to $999,999,999.00 through December 2026 and serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.

AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor and critical federal vendor specializing in providing a comprehensive range of medical products including vaccines, medications, and medical devices to military and veteran healthcare systems. The company's extensive experience fulfilling federal pharmaceutical procurement requirements through open competition demonstrates its capability to meet government medical supply needs. The M-M-R II vaccine procurement supports the Defense Health Agency and other military treatment facilities' immunization programs, leveraging the established prime vendor relationship to efficiently deliver essential vaccines to support military healthcare operations.